# Putting Patients First in Drug Development | Applied Clinical Trials Online > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/patient-centered-drug-development-cannabis-research/ > **Published:** 2026-04-08T06:02:09-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:56:36-04:00 > **Clinical Summary:** Explore patient-centered drug development approaches in cannabis research emphasizing real-world evidence and patient-reported outcomes. --- ✦ New CED Clinical Relevance  #80High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic [Clinical Research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/)Patient-Centered CareReal-World Evidence[Drug Development](https://cedclinic.com/hydrogen-sulfide-releasing-nsaid-derivative/)Patient-Reported Outcomes Why This Matters Patient-centered [drug development](https://cedclinic.com/hydrogen-sulfide-releasing-nsaid-derivative/) approaches are increasingly relevant in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/), where traditional clinical trial frameworks often fail to capture the complex, individualized dosing patterns and poly-symptomatic relief that characterize real-world [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/). This methodology shift could accelerate evidence generation for cannabis therapeutics that have been historically difficult to study through conventional RCT designs. Clinical Summary Patient-centered drug development prioritizes patient experiences, outcomes, and preferences throughout the research process rather than relegating patient input to post-market surveillance. This approach emphasizes real-world evidence, patient-reported outcomes, and adaptive trial designs that can accommodate the heterogeneous responses seen in complex therapeutics. For [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/), this framework acknowledges that patients often titrate doses based on symptom relief across multiple conditions simultaneously, making traditional single-indication, fixed-dose studies less clinically relevant. Dr. Caplan’s Take “In my practice, patients consistently demonstrate more sophisticated understanding of their cannabis responses than our current research infrastructure captures. Patient-centered development could finally bridge the gap between what patients experience and what we can measure in clinical studies.” Clinical Perspective 🧠 Clinicians should recognize that patient-reported cannabis experiences, when systematically collected, may provide more clinically actionable data than traditional efficacy endpoints. This approach validates the collaborative dosing conversations already happening in cannabis medicine and suggests that structured patient feedback could accelerate therapeutic development. Watch for research initiatives that incorporate patient advisory boards and real-world evidence collection in cannabis studies. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Putting%20Patients%20First%20in%20Drug%20Development%20%7C%20Applied%20Clinical%20Trials%20Online%20%40drcaplan&url=https%3A//www.appliedclinicaltrialsonline.com/view/putting-patients-first-in-drug-development)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.appliedclinicaltrialsonline.com/view/putting-patients-first-in-drug-development)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Putting%20Patients%20First%20in%20Drug%20Development%20%7C%20Applied%20Clinical%20Trials%20Online%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.appliedclinicaltrialsonline.com/view/putting-patients-first-in-drug-development)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.appliedclinicaltrialsonline.com/view/putting-patients-first-in-drug-development](https://www.appliedclinicaltrialsonline.com/view/putting-patients-first-in-drug-development) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis research?](#What_is_the_clinical_relevance_rating_of_this_cannabis_research) - [What type of cannabis research is being discussed?](#What_type_of_cannabis_research_is_being_discussed) - [Why is this research considered clinically significant?](#Why_is_this_research_considered_clinically_significant) - [What makes this a “patient-centered” cannabis study?](#What_makes_this_a_8220patient-centered8221_cannabis_study) - [How does this research contribute to cannabis drug development?](#How_does_this_research_contribute_to_cannabis_drug_development) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis research? This research has been assigned a “High Clinical Relevance” rating (#80). This indicates strong evidence or policy relevance with direct clinical implications for healthcare practice. #### What type of cannabis research is being discussed? This appears to be [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) focused on patient-centered care approaches. The study involves real-world evidence collection and drug development aspects related to cannabis therapeutics. #### Why is this research considered clinically significant? The high clinical relevance rating suggests this research provides strong evidence that can directly impact [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) decisions. It combines clinical research methodologies with real-world patient outcomes data. #### What makes this a “patient-centered” cannabis study? Patient-centered care focuses on involving patients in treatment decisions and considering their preferences and experiences. This research likely examines how cannabis treatments affect real patients in clinical settings rather than just laboratory conditions. #### How does this research contribute to cannabis drug development? By combining clinical research with real-world evidence, this study provides valuable data for developing cannabis-based medications. The findings can inform dosing, efficacy, and safety profiles needed for regulatory approval and clinical guidelines. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Rescheduling marijuana would open the doors for researchers to study THC and CBD.](https://cedclinic.com/rescheduling-marijuana-research-barriers-thc-cbd-studies/) Learn how marijuana rescheduling could enhance research opportunities for THC and CBD, supporting patient-centered drug development. [Read More](https://cedclinic.com/rescheduling-marijuana-research-barriers-thc-cbd-studies/) [Cannabinoids in Pediatric Medicine: Evidence-Based Care and Emerging Research](https://cedclinic.com/cannabinoids-pediatric-clinical-evidence-review/) Explore emerging research on cannabinoids in pediatric medicine emphasizing evidence-based and patient-centered approaches. [Explore Now](https://cedclinic.com/cannabinoids-pediatric-clinical-evidence-review/) [UW study: Gap in doctors' knowledge on cannabis | FOX 13 Seattle](https://cedclinic.com/physician-training-cannabis-knowledge-gap-uw-study/) Discover findings on the knowledge gap among doctors regarding cannabis, highlighting the need for patient-centered education. [Learn More](https://cedclinic.com/physician-training-cannabis-knowledge-gap-uw-study/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).